| Статус: | Unknown status |
| Фаза: | не указано |
| Начало: | 28 апреля 2020 г. |
| Окончание: | 1 сентября 2023 г. |
| Описание: | This study was designed to evaluate the efficacy and safety of Extimia® (INN - empegfilgrastim) in reducing the frequency, duration of neutropenia, the incidence of febrile neutropenia and infections caused by febrile neutropenia in patients with High and "Gray Zone" Risk Reccurrence Breast Cancer, Gastointestinal Cancers and Gynecological Malignancies |
| смотреть на ClinicalTrials.gov |
| Статус: | Unknown status |
| Фаза: | Phase 2 |
| Начало: | 10 июля 2017 г. |
| Окончание: | 10 июля 2020 г. |
| Описание: | This study is conducted to evaluate efficacy and safety of neoadjuvant chemotherapy followed by preoperative chemoradiotherapy in patients with resectable esophageal squamous cell carcinoma |
| смотреть на ClinicalTrials.gov |